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Abstract
Background: More severe and persistent forms of affective disorders are accompanied by grey matter loss in key
frontal and temporal structures. It is unclear whether such changes precede the onset of illness, occur early in the
course or develop gradually with persistence or recurrence of illness. A total of 47 young people presenting with
admixtures of depressive and psychotic symptoms were recruited from specialist early intervention services along
with 33 age matched healthy control subjects. All participants underwent magnetic resonance imaging and
patients were rated clinically as to current stage of illness. Twenty-three patients were identified as being at an
early ‘attenuated syndrome’ stage, while the remaining were rated as having already reached the ‘discrete disorder’
or ‘persistent or recurrent illness’ stage. Contrasts were carried out between controls subjects and patients cohorts
with attenuated syndromes and discrete disorders, separately.
Results: The patients that were identified as having a discrete or persisting disorder demonstrated decreased grey
matter volumes within distributed frontal brain regions when contrasted to both the control subjects as well as
those patients in the attenuated syndrome stage. Overall, patients who were diagnosed as more advanced in
terms of the clinical stage of their illness, exhibited the greatest grey matter volume loss of all groups.
Conclusions: This study suggests that, in terms of frontal grey matter changes, a major transition point may occur
in the course of affective illness between early attenuated syndromes and later discrete illness stages.
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Background
Structural neuroimaging studies in patients with estab-
lished affective and psychotic disorders have emphasised
the extent to which discrete regions of fronto-temporal
grey matter are selectively diminished [1-3]. Most stu-
dies, however, have focused on patient cohorts at the
more severe and persistent illness end of the spectrum
[4]. In some studies, key structural changes such as
reduced hippocampal volume have been more marked
in late-onset, as distinct from early onset, cases [5-7].
There is a paucity of studies that have characterised
structural brain changes prior to onset or during the
early stages of these disorders. As compared with studies
related to psychosis onset [2,8] little is known about
potential grey matter changes that occur when patients
transition from earlier to later phases of illness. This is
particularly pertinent, since better understanding the
trajectory of the disease process may provide enhanced
opportunities for the development of more effective
early intervention strategies [9-12].
To this end, we have developed a clinical staging
model for application in the early phases of illness of
patients who present with admixtures of anxiety, depres-
sive or psychotic symptoms [13]. It attempts to identify
closer links between early clinical phenotypes and dis-
crete pathways to illness [14,15]. Young help seeking
individuals with mixed symptoms are typically closer to
their illness onset than middle-aged adults with discrete
disorders. “Detailed clinical and neurobiological exami-
nation of these individuals (in cross-section and longi-
tudinally) may provide a window of opportunity for
identifying core neurobiological characteristics of the ill-
n e s s( i . e .d i s e a s eb i o m a r k e r s )t h a ta r ei n d e p e n d e n to f
the effects of persisting or recurrent illness, comorbid
alcohol or other substance misuse.”
* Correspondence: jim.lagopoulos@sydney.edu.au
† Contributed equally
Clinical Research Unit, Brain and Mind Research Institute, University of
Sydney, Australia
Lagopoulos et al. BMC Psychiatry 2012, 12:4
http://www.biomedcentral.com/1471-244X/12/4
© 2012 Lagopoulos et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.The principal aim of this study was to test whether
there are distinct patterns of grey matter changes evi-
dent very early in the course of affective illness and
whether these patterns differ from those seen in subjects
who have progressed to later stages. We hypothesised
that there would be a gradation of structural deficits
associated with transition from early to later clinical
stages. Specifically, we hypothesised that grey matter
changes would be more extensive in those with discrete
disorders (and as such at later stages of illness), as com-
pared to those with earlier sub-syndromal or attenuated
syndromes.
Results
Sample characteristics
Whilst the various clinical stages did not differ in terms
of the education (years) they did differ in terms of age [t
(df = 38.6) = -2.4, p=.023], with the help-seeking/attenu-
ated syndrome (stage 1) group being approximately 3
years younger than the discrete disorder/persistent ill-
ness group (stages 2/3). The stage 1 group as compared
with the stage 2/3 group did not differ in predicted IQ
(see Table 1); nor did they differ in clinical ratings for
current social and occupational functioning (SOFAS),
depressive symptoms (HDRS), self-reported psychologi-
cal distress (K10), or general psychiatric symptoms
(indexed by BPRS total; see Table 1).
For symptoms potentially indicative of more severe
syndromes, 35% of the help-seeking/attenuated syn-
drome group reported bipolar-like symptoms compared
to 30% of the discrete disorder/persistent illness group;
whereas only 9% of the help-seeking/attenuated syn-
drome group reported psychotic symptoms compared to
54% of the discrete disorder/persistent illness group.
With regards to medication, less than 13% of cases were
receiving no medication, and antidepressants were used
equally across the different stages. However, more indi-
viduals in the later stages tended to receive additional
antipsychotic (48% vs. 71%) or mood stabilizing (13% vs.
46%) medicines (see Table 2).
Imaging data
Healthy controls vs stage 1: Loss of grey matter volume
was evident in the amygdala and precuneus on the right
side as well as the insula on the left for the stage 1 sub-
jects (see Table 3 and Figure 1).
Healthy controls vs stage 2/3: Significant loss of grey
matter volume was evident for the stage 2/3 group as
compared to the controls in the following brain regions:
middle and inferior frontal gyri on the right and medial
prefrontal, orbitofrontal and subcallosal cortices, mid-
line. Significant grey matter loss was also present in the
left insula and parahippocampal gyrus as well as the
head of caudate, bilaterally (see Table 3 and Figure 1).
Stage 1 vs stage 2/3: Significantly decreased grey mat-
ter volume was evident for the discrete disorder/persis-
tent illness sample, only (see Table 3 and Figure 1). The
largest cluster was located on an overlapping region
between the superior and middle frontal gyrus on the
right side. The greatest grey matter volume loss
occurred predominantly in the superior frontal gyrus
from which it extended inferio-anteriorly to the middle
frontal gyrus. Grey matter volume was also significantly
decreased in the middle frontal gyrus on the left, the
inferior frontal gyrus and anterior cingulate on the right
cerebrum and the medial prefrontal cortex midline and
orbitofrontal cortex on the right.
Discussion
This study investigated the extent to which grey matter
loss occurs across clinical stages in young outpatients
with an admixture of depression and other common
psychiatric symptoms. Significant loss of frontal grey
matter volume is characteristic of those in later stages
where patients exhibit symptoms consistent with a dis-
crete or persisting illness as compared with their peers
Table 1 Demographic and clinical variables
Healthy Controls
[N = 33]
Help-Seeking/Attenuated Syndrome
(stage 1) [N = 23]
Discrete Disorder/Persistent or Recurrent
Illness (stage 2/3) [N = 24]
Significance Test
(df) [p value]
Sex (f/m) 21/12 15/8 10/14 c2 (80) = 3.5 [.171]
Age, years 23.9 ± 2.3 20.4 ± 5.2 23.5 ± 3.5 t (38.5) = -2.4 [.023]
Education,
years
15.2 ± 2.2 12.1 ± 3.0 13.1 ± 2.6 t (38) = -1.1 [.281]
Predicted
IQ
105.8 ± 8.5 105.0 ± 6.6 105.1 ± 6.6 t (39) = 0.1 [.899]
SOFAS 91.9 ± 3.5 65.3 ± 9.9 58.7 ± 13.4 t (34) = 1.7 [.104]
K-10 total 15.3 ± 6.1 26.4 ± 7.3 22.0 ± 7.0 t (40) = 2.0 [.055]
HDRS total 1.7 ± 1.7 10.6 ± 6.7 10.2 ± 7.6 t (36) = 0.2 [.878]
BPRS total 26.2 ± 2.2 37.1 ± 7.5 42.4 ± 10.7 t (35) = -1.7 [.090]
Mean scores (± standard deviation) for demographic and clinical variables across groups. Statistical tests are between stage 1 and stage 2/3 cohorts. Group
differences were tested using chi-square or -test.
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pattern was characterised by a distributed loss of grey
matter across a major portion of the prefrontal cortex
with the greatest loss occurring within an overlapping
region bounded by the superior and middle frontal gyri
on the right side. Additional loss of grey matter volume
was also observed in the inferior aspects of the frontal
g y r u sa sw e l la st h ea n t e r i o rc i n g u l a t ea n dt h eo r b i t o -
frontal cortex on the right side as well as the medial
prefrontal cortex midline. The pattern of grey matter
loss also extended to the middle and inferior frontal gyri
on the left side. When compared to healthy control sub-
jects, stage 2/3 patients exhibited a similar pattern of
grey matter loss, to that identified when compared to
patients with attenuated symptoms, although the degree
of volume loss was more extensive in the former com-
parison. In contrast when patients with attenuated
symptoms were compared to controls the extent of the
grey matter loss was markedly less. The results from
this comparison indicated that the insula, amygdala and
the precuneus were the initial brain regions affected.
However, interestingly, grey matter changes within the
amygdala and precuneus did not reach statistical signifi-
cance for the more severe stage 2/3 group. This may
suggest the grey matter loss observed in these regions
for the stage 1 patient group might be related to the
patient cohort per se rather than it being an early indi-
cator of a disease trajectory. Longitudinal studies with
larger patient cohorts would need to be conducted so as
to explicate this finding.
Table 2 Medication variables
Current Medication Help-Seeking/Attenuated Syndrome [Count (%)] Discrete Disorder/Persistent or Recurrent Illness [Count (%)]
Nil 3 (13.0) 2 (8.3)
Any Antidepressant 14 (60.8) 13 (54.2)
Any Antipsychotic 11 (47.8) 17 (70.8)
Any Mood Stabiliser 3 (13.0) 11 (45.8)
Cross-tabulation of clinical stage group by current medication.
Table 3 Grey matter results
Cortical Area Hemisphere MNI Coordinates Brodmann Area Cluster size (mm
3) Corrected p-value
Healthy Control vs Attenuated Sydnrome
Amygdala right 28, -8, -14 2894 0.05
Precuneus right 14, -74, 34 7 3710 0.05
Insula left -42, -8, -8 13, 14 4156 0.05
Healthy Control vs Discrete Disorder
Middle frontal gyrus right 26, 46, 34 46 9088 0.01
Anterior cingulate cortex midline 0, 36, 12 24 6748 0.01
Inferior frontal gyrus right 46, 40, 10 10 4034 0.01
Caudate nucleus (head) right 6, 12, 2 1799 0.01
Caudate nucleus (head) left -6, 12, 2 1907 0.01
Parahippocampal gyrus left -10, -42, 2 36 2019 0.01
Insula left -36, -24, 12 13, 14 5973 0.01
Medial prefrontal cortex midline 0, 32, -16 9 9634 0.002
Orbitofrontal cortex midline 0, 34, -26 10 9858 0.01
Subcallosal cortex midline 0, 10, -8 7590 0.01
Attenuated Sydnrome vs Discrete Disorder
Superior frontal gyrus right 26, 30, 38 8, 9 8942 0.01
Middle frontal gyrus right 36, 30, 24 46 7429 0.01
Middle frontal gyrus left -24, 22, 40 46 3830 0.01
Inferior frontal gyrus right 40, 40, 8 10 6861 0.01
Inferior frontal gyrus left -46, 36, 8 10 4102 0.01
Anterior cingulate cortex right 2, 40, 20 24 3642 0.02
Orbitofrontal cortex right 26, 54, -4 10 4296 0.01
Medial prefrontal cortex midline 0, 22, 20 9 3487 0.004
Results of significant clusters of grey matter volume loss for the right and left hemispheres for the following contrasts: (i) healthy controls vs attenuated
syndrome, (ii) healthy controls vs discrete disorder and (iii) attenuated syndrome vs discrete disorder. Cortical coordinates are reported in MNI space, and cluster
size in mm
3
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across the clinical stages and healthy controls support
our hypothesis that grey matter changes are more exten-
sive in those with later or discrete disorders, as com-
pared to those with earlier sub-syndromal or attenuated
syndromes. Our results are consistent with those few
other studies that have employed similar staging para-
digms, that is, to categorise patients with psychotic dis-
orders on the basis of illness progression rather than
predefined diagnostic criteria [2,16]. While there is over-
lap between the patterns of grey matter loss observed in
those studies (particularly within the prefrontal cortex)
when compared to our current study, there are also
important differences. Specifically, in these patients who
present predominantly with depressive disorders, we did
not find any evidence of grey matter loss that extended
outside the prefrontal cortex. Those studies (largely of
patients with emerging psychosis) that have employed a
similar staging paradigm (both cross sectional and longi-
tudinally) have reported more widespread grey matter
loss that encompasses regions including the parahippo-
campal, fusiform and cerebellar cortices [2], temporal
lobes [17] as well as the cerebellum and amygdala [18].
Whilst the changes in later stages were confined to
the prefrontal cortex, they do bear similarities to those
seen in ‘high-risk’ (or attenuated psychosis) patients
before and after transitioning to first episode psychosis.
Most of these studies have reported predominant right
side pathology that incorporate the orbitofrontal, super-
ior, medial cortices as well as the anterior cingulate cor-
tex [16]. Indeed the established schizophrenia/psychosis
literature is burgeoning with volumetric studies that
report loss of grey matter in the aforementioned regions
but invariably to a greater extent both in terms of spa-
tial distribution but also degree of grey matter loss. Our
patient cohort was comprised of help seeking adoles-
cents and young adults who presented with a variety of
risk criteria and attenuated anxiety, depressive, hypoma-
nic and/or psychotic symptoms. As such, our patients
constitute a very heterogeneous group, with a significant
percentage likely to go on and develop more persistent
affective or psychotic disorders. However, we expect
that they will not all take the same trajectory and that
only a small minority may ever transition to well-estab-
lished major depressive, bipolar or psychotic disorders
[19]. These differences in illness trajectories are likely to
explain differences between our study and those, which
are based on more narrowly, focused cohorts of patients
selected to be at risk of psychosis. Interestingly, the few
longitudinal studies that have been conducted on at-risk
psychosis groups, have reported significantly decreased
grey matter volume within the inferior frontal gyrus and
superior temporal gyrus (both on the right side) in
those patients that transitioned into full-blown disease
[20]. This suggests that in the case of more pure forms
of psychosis, the disease process preferentially targets
these two regions.
In our current study we did not find any evidence of
grey matter loss in the superior temporal gyrus however
we did detect significant grey matter loss in the inferior
frontal gyrus (bilaterally) amongst other prefrontal corti-
cal regions. Our results would suggest that the inferior
frontal gyrus may be a region that is targeted more
Figure 1 VBM grey matter results. Group difference, grey matter
volume maps rendered on the MNI152 structural template.
Statistically significant clusters of grey matter changes calculated
using 23 patients at stage 1 (i.e. help-seeking/attenuated syndrome),
24 patients at stage 2/3 (i.e. discrete disorder/persistent or recurrent
illness) and 33 healthy control subjects. Contrast 1 depicts healthy
control subjects versus stage 1 subjects (grey matter loss occurring
at stage 1 is presented in orange). Contrast 2 depicts healthy
controls versus stage 2/3 (grey matter loss is presented in blue).
Finally contrast 3 depicts grey matter volume changes in stage 1
versus stage 2/3 subjects (regions of significant grey matter loss are
presented in green). Abbreviations are as follows: SFG = superior
frontal gyrus; OFC = orbito frontal cortex; IFG = inferior frontal
gyrus; MFG = middle frontal gyrus; ACG = anterior cingulate gyrus;
Cing = cingulate; Ins = insula; Amyg = amygdala; MedFC = medial
frontal gyrus; Caud = caudate; PHG = parahippocampal gyrus; SCC
= subcallosal cortex. Images are radiologically oriented.
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might not be confined only to the development of psy-
chosis. If this finding can be replicated and is indeed
robust, this could potentially provide a neuroimaging
target that could be monitored in patients who may be,
in the first instance help seeking or that carry an
increased risk of developing a major psychiatric illness.
It is striking that our findings of decreased grey matter
volume were predominantly confined to the prefrontal
cortex and interestingly to specific regions therein
which are putatively involved in the integration and reg-
ulation of behaviours. The superior and middle frontal
gyri are regions widely reported to be involved in the
executive functioning including decision making [21]
and memory [22] both of which were found to be com-
promised in our more severe cohort. Moreover, the
anterior cingulate (and more specifically its ventral
aspect) and the orbitofrontal cortex are both involved
with emotion-based decision making including the eva-
luation of risk and reward [23]. The structural changes
uncovered within these areas are consistent with the
wide-ranging symptoms exhibited by our patient cohort
that includes mood, anxiety and psychotic symptoms.
There were several methodological limitations asso-
ciated with our study. Firstly, the size for our patient
cohorts, whilst adequately powered were modest in
comparison to larger cross sectional studies that have
investigated patients with established disease. As such
we can’t exclude the possibility that some grey matter
changes (notably within some key temporal lobe struc-
tures) may not have attained statistical significance. A
further limitation is associated with the potential con-
found of medication. Our discrete disorder/persistent ill-
ness cohorts were on average more likely to be receiving
multiple medications than the help-seeking/attenuated
syndrome group. Finally, longitudinal experimental
designs with large cohorts are urgently needed (with
scanning occurring prior to and following transition to a
major psychiatric illness, and including patients who
move to different eventual disorder outcomes such as
bipolar and other discrete psychotic disorders) to sepa-
rate out early shared changes from those that may be
more characteristic of either later stages of all illnesses
or isolated to particular clinical phenotypes.
Conclusions
The results of our study indicate that there is a gradation
of grey matter loss occurring in patients categorised by
our clinical staging model. Patients presenting with a dis-
crete or persistent illness (categorised as stage 2/3) had
extensive grey matter loss predominantly within the pre-
frontal cortex as compared to help seeking individuals.
Moreover, our findings suggest that discernable patterns
of grey matter loss are indicative of stage of illness.
Methods
Forty-seven health seeking participants aged 14 to 29
years were recruited from a specialised tertiary referral
service for assessment and early intervention of mental
health problems in young people [24,25] as part of a
longitudinal study of youth mental health at the Brain
and Mind Research Institute (BMRI), Sydney, Australia.
Inclusion criterion for this sub-study were: i) persons
aged 12-30 years seeking professional help primarily for
significant anxiety, depressive, hypomanic or psychotic
symptoms and, ii) willingness to participate in other
neurobiological and longitudinal research with the
BMRI related to clinical outcomes [26]. As such, this
cohort represents a selected sub-set of a much broader
cohort (n = 1483, 1260 of whom were aged 12-25 years)
who presented to our services for clinical care during
t h es a m et i m ep e r i o d[ 2 5 ] .I na d d i t i o n3 3h e a l t h yc o n -
trol subjects (age range 15 to 28) were also recruited
from the general population.
Subjects were excluded if they did not have sufficient
English-language skills or had insufficient intellectual
capacity to participate in the neuropsychological aspects
of the concurrent studies [27]. The Human Research
Ethics Committee of the University of Sydney approved
this study, and all patients gave prospective written
informed consent for their clinical data to be used for
research purposes. Parental consent was obtained for
patients under 18 years of age.
All patients who entered the services were assessed
and managed by medically and/or psychologically-
trained health professionals [28]. In this sub-study, an
independent psychiatrist or trained research psychologist
also conducted a standardized clinical interview, focus-
ing on assessment of the detailed criteria developed for
formal application of our clinical staging framework
[13,28]. For those who are assessed in clinical environ-
ments, discrete categories (stages 1 to 4; whereby, stage
1a = ‘help-seeking’;s t a g e1 b=‘attenuated syndrome’;
stage 2 = ‘discrete disorder’;s t a g e3=‘persistent or
recurrent illness’;a n ds t a g e4=‘chronic debilitating ill-
ness’) are described. A key point of differentiation, how-
ever, occurs between those early ‘sub-threshold’
syndromes (classed as stage 1a or 1b) and the onset
(stage 2) of a more discrete disorder. Importantly, entry
to stage 2 was not simply analogous to, or defined by,
meeting existing DSM or ICD criteria for a specific
mood or psychotic disorder. At the time of scan 23
patients were identified to be at the ‘attenuated syn-
drome’ [stage 1b] (15 females) and 24 were rated to be
within the ‘discrete disorder’ [stage 2] (N = 13; 5
females) or ‘persistent or recurrent illness’ [stage 3] (N
= 11; 5 females) stage. The stage 2/3 cohorts included
patients with a diagnosis of bipolar disorder, depression
and psychosis. To ensure consistent inter-rater reliability
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pared the determination of clinical stage by the original
treating clinician with that assigned by the consensus
pairs working from the records. The key comparison
was for the degree of concordance between ratings of
‘sub-syndromal or attenuated states’ (stage 1) versus
later established disorders (stages 2-4); ii) second, the
ratings derived from a consensus pair were compared
with that derived by an independent rater from our
research team.
All imaging was conducted at the BMRI imaging facil-
ity using a 3T GE Discovery MR750 scanner (GE Medical
Systems, Milwaukee, WI). Structural images were
acquired using an 8-channel phased array head coil using
a T1-weighted magnetization prepared rapid gradient-
echo (MPRAGE) sequence producing 196 sagittal slices
(TR = 7.2 ms; TE = 2.8 ms; flip angle = 10°; matrix 256 ×
256; 0.9 mm isotropic voxels). For each subject, two T1-
weighted MRI scans were obtained in single scan ses-
sions, and individual structural whole brain MRI’sw e r e
averaged to increase signal-to-noise ratio.
An unbiased optimised VBM analysis was carried out
using FSL (FMRIB Software Library, http://www.fmrib.
ox.ac.uk/fsl, Smith et al., 2004) with no a priori informa-
tion regarding possible loci of structural changes in the
grey matter. The FSL-VBM analysis pipeline was then
conducted as follows. Firstly, brain tissue was extracted
prior to tissue-type segmentation using BET [29]. All
T1-weighted images were then transformed into stan-
dard space using a limited degrees-of-freedom non-lin-
ear model to ensure maximum spatial alignment and
images were corrected for non-uniformity. The FAST4
[30] tool was then applied to segment tissues according
to their type. The segmented grey matter partial volume
images were then aligned into the MNI standard space
by applying the affine registration tool FLIRT [31,32]
and nonlinear registration FNIRT [33,34] methods,
which use a B-spline representation of the registration
warp field [35]. An averaged study-specific template was
then created using all the unsmoothed images to which
the grey matter partial volume images were re-registered
and these registered images were then modulated to
correct for local expansion and contraction by the Jaco-
bian of the warp field. Rigorous visual inspection was
used to ensure the quality of brain image extraction,
segmentation, and registration for each averaged struc-
tural image. The modulated, segmented images were
then smoothed with an isotropic Gaussian kernal with 3
mm standard deviation (FWHM 7.05 mm). The most
common quality control issue encountered was subopti-
mal brain extraction using the BET tool. This was evi-
dent in brain-extracted images, which had unwanted
skull and neck tissue included as part of the final pro-
cessed image. In such instances it was necessary to re-
r u nt h eb r a i ne x t r a c t i o ns t e pu s i n gt h e“bias field cor-
rection and neck cleanup” option in BET.
Finally, permutation-based non-parametric testing,
using a 5000 permutation set was used in a voxel-wise
GLM [36] for contrasting differences between (i) healthy
controls versus stage 1 patients (help-seeking/attenuated
syndrome), (ii) healthy controls versus stage 2/3 (dis-
crete disorder/persistent or recurrent illness) which
depicts a more established disease process and finally
(iii) stage 1 versus stages 2/3. To identify regionally spe-
cific associations that were not confounded by differ-
ences in age and total intracranial volume across the
three groups, both these variables were entered into the
design matrix as confounding covariates. Family-wise
error (FWE) correction [37] was used to correct the
threshold for multiple comparisons across space and
threshold-free cluster enhancement was employed to
assess cluster significance [38]. The significant p-value
with the FWE corrected threshold was set at p < 0.05.
Acknowledgements and Funding
This study was supported by the NHMRC Program Grant (No. 566529),
Centres of Clinical Research Excellence Grant (No. 264611), NHMRC Australia
Fellowship (No. 511921) and Clinical Research Fellowship (No. 402864).
Authors’ contributions
JL carried out the imaging analysis, and drafted the manuscript. IBH, SLN
and DFH conceived of the study, and participated in its design and
coordination and helped to draft the manuscript. EMS participated in the
design of the study and performed the clinical assessments. All authors
contributed significantly to the interpretation of the data as well as having
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 26 October 2011 Accepted: 20 January 2012
Published: 20 January 2012
References
1. Bora E, Fornito A, Pantelis C, Yucel M: Gray matter abnormalities in Major
Depressive Disorder: A meta-analysis of voxel based morphometry
studies. J Affect Disord 2011.
2. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ,
Yung AR, Bullmore ET, Brewer W, Soulsby B, et al: Neuroanatomical
abnormalities before and after onset of psychosis: a cross-sectional and
longitudinal MRI comparison. Lancet 2003, 361:281-288.
3. Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R,
Cannon DM, Neumeister A, Zarate CA Jr, Drevets WC: Prefrontal cortical
abnormalities in currently depressed versus currently remitted patients
with major depressive disorder. Neuroimage 2011, 54:2643-2651.
4. Lagopoulos J, Malhi G: Impairments in “top-down” processing in bipolar
disorder: a simultaneous fMRI-GSR study. Psychiatry Res 2011, 192:100-108.
5. Hickie I, Naismith S, Ward PB, Turner K, Scott E, Mitchell P, Wilhelm K,
Parker G: Reduced hippocampal volumes and memory loss in patients
with early- and late-onset depression. Br J Psychiatry 2005, 186:197-202.
6. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT,
Nahmias C, Young LT: Course of illness, hippocampal function, and
hippocampal volume in major depression. Proc Natl Acad Sci USA 2003,
100:1387-1392.
7. Campbell S, Marriott M, Nahmias C, MacQueen GM: Lower hippocampal
volume in patients suffering from depression: a meta-analysis. Am J
Psychiatry 2004, 161:598-607.
Lagopoulos et al. BMC Psychiatry 2012, 12:4
http://www.biomedcentral.com/1471-244X/12/4
Page 6 of 78. Bora E, Fornito A, Radua J, Walterfang M, Seal M, Wood SJ, Yucel M,
Velakoulis D, Pantelis C: Neuroanatomical abnormalities in schizophrenia:
a multimodal voxelwise meta-analysis and meta-regression analysis.
Schizophr Res 2011, 127:46-57.
9. Insel TR: Translating scientific opportunity into public health impact: a
strategic plan for research on mental illness. Arch Gen Psychiatry 2009,
66:128-133.
10. Insel TR: The arrival of preemptive psychiatry. Early Intervention in
Psychiatry 2007, 1:5-6.
11. McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ: Clinical
staging: a heuristic model for psychiatry and youth mental health. Med J
Aust 2007, 187:S40.
12. Hickie IB: Youth mental health: we know where we are and we can now
say where we need to go next. Early Intervention in Psychiatry 2011,
5:63-69.
13. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ: Clinical staging of
psychiatric disorders: a heuristic framework for choosing earlier, safer
and more effective interventions. Aust N Z J Psychiatry 2006, 40:616-622.
14. Hickie IB, McGorry PD: Characterising novel pathways to schizophrenia.
Med J Aust 2009, 190:S5-6.
15. McGorry PD, Tanti C, Stokes R, Hickie IB, Carnell K, Littlefield LK, Moran J:
headspace: Australia’s National Youth Mental Health Foundation–where
young minds come first. Med J Aust 2007, 187:S68-70.
16. Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pfluger MO,
Stieglitz RD, Radue EW, Riecher-Rossler A: Reductions in frontal, temporal
and parietal volume associated with the onset of psychosis. Schizophr
Res 2008, 106:108-114.
17. Lawrie SM, Whalley HC, Abukmeil SS, Kestelman JN, Miller P, Best JJ,
Owens DG, Johnstone EC: Temporal lobe volume changes in people at
high risk of schizophrenia with psychotic symptoms. Br J Psychiatry 2002,
181:138-143.
18. Job DE, Whalley HC, Johnstone EC, Lawrie SM: Grey matter changes over
time in high risk subjects developing schizophrenia. Neuroimage 2005,
25:1023-1030.
19. Hickie IB: Youth mental health: we know where we are and we can now
say where we need to go next. Early Interv Psychiatry 2011, 5(Suppl
1):63-69.
20. Fusar-Poli P, Borgwardt S, Crescini A, Deste G, Kempton MJ, Lawrie S, Mc
Guire P, Sacchetti E: Neuroanatomy of vulnerability to psychosis: a voxel-
based meta-analysis. Neurosci Biobehav Rev 2011, 35:1175-1185.
21. Lagopoulos J, Malhi GS: A functional magnetic resonance imaging study
of emotional Stroop in euthymic bipolar disorder. Neuroreport 2007,
18:1583-1587.
22. Lagopoulos J, Ivanovski B, Malhi GS: An event-related functional MRI
study of working memory in euthymic bipolar disorder. J Psychiatry
Neurosci 2007, 32:174-184.
23. Carballedo A, Scheuerecker J, Meisenzahl E, Schoepf V, Bokde A, Moller HJ,
Doyle M, Wiesmann M, Frodl T: Functional connectivity of emotional
processing in depression. J Affect Disord 2011.
24. Scott E, Naismith SL, Whitwell BG, Hamilton B, Chudleigh C, Hickie IB:
Delivering youth-specific mental health services: the advantages of a
collaborative, multi-disciplinary system. Australas 2009, 17:189-194.
25. Scott E, Hermens D, Glozier N, Naismith S, Guastella A, Hickie I: Targeted
primary care-based mental health services engage young Australians in
treatment. Medical Journal of Australia 2011.
26. Hermens DF, Redoblado Hodge MA, Naismith SL, Kaur M, Scott E, Hickie IB:
Neuropsychological clustering highlights cognitive differences in young
people presenting with depressive symptoms. J Int Neuropsychol Soc
2011, 17:267-276.
27. Hermens DF, Naismith SL, Redoblado Hodge MA, Scott EM, Hickie IB:
Impaired verbal memory in young adults with unipolar and bipolar
depression. Early Interv Psychiatry 2010, 4:227-233.
28. Hamilton BA, Naismith SL, Scott EM, Purcell S, Hickie IB: Disability is already
pronounced in young people with early stages of affective disorders:
data from an early intervention service. J Affect Disord 2011, 131:84-91.
29. Smith SM: Fast robust automated brain extraction. Hum Brain Mapp 2002,
17:143-155.
30. Zhang Y, Brady M, Smith S: Segmentation of brain MR images through a
hidden Markov random field model and the expectation-maximization
algorithm. Medical Imaging, IEEE Transactions on 2001, 20:45-57.
31. Jenkinson M, Smith S: A global optimisation method for robust affine
registration of brain images. Medical Image Analysis 2001, 5:143-156.
32. Jenkinson M, Bannister P, Brady M, Smith S: Improved Optimization for the
Robust and Accurate Linear Registration and Motion Correction of Brain
Images. Neuroimage 2002, 17:825-841.
33. Non-linear optimisation. FMRIB technical report TR07JA1. [http://www.
fmrib.ox.ac.uk/analysis/techrep].
34. Non-linear registration, aka spatial normalisation. FMRIB technical report
TR07JA2. [http://www. fmrib.ox.ac.uk/analysis/techrep].
35. Rueckert D, Sonoda LI, Hayes C, Hill DLG, Leach MO, Hawkes DJ: Nonrigid
registration using free-form deformations: application to breast MR
images. Medical Imaging, IEEE Transactions on 1999, 18:712-721.
36. Nichols TE, Holmes AP: Nonparametric permutation tests for functional
neuroimaging: A primer with examples. Hum Brain Mapp 2002, 15:1-25.
37. Nichols T, Hayasaka S: Controlling the familywise error rate in functional
neuroimaging: a comparative review. Statistical Methods in Medical
Research 2003, 12:419-446.
38. Smith SM, Nichols TE: Threshold-free cluster enhancement: Addressing
problems of smoothing, threshold dependence and localisation in
cluster inference. Neuroimage 2009, 44:83-98.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-244X/12/4/prepub
doi:10.1186/1471-244X-12-4
Cite this article as: Lagopoulos et al.: Frontal lobe changes occur early
in the course of affective disorders in young people. BMC Psychiatry
2012 12:4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lagopoulos et al. BMC Psychiatry 2012, 12:4
http://www.biomedcentral.com/1471-244X/12/4
Page 7 of 7